Effect of anagrelide on JAK2 mutational status in patients with essential thrombocythemia
2008
Online
unknown
Zugriff:
We evaluated the effect of anagrelide (ANA) in 9 of 22 patients with essential thrombocythemia (ET) who had a JAK2 V617F mutation and polycythemia vera (PV)–like disease. First, we observed a successful reduction of JAK2 mutation, which was associated with disappearance of PV-like phenotype. Second, we found that a level of JAK2 mutation
Titel: |
Effect of anagrelide on JAK2 mutational status in patients with essential thrombocythemia
|
---|---|
Autor/in / Beteiligte Person: | Ernesto Di Francesco ; Cacciola, Emma ; Cacciola, Rossella R. ; Pezzella, Francesca ; Tibullo, Daniele |
Link: | |
Veröffentlichung: | 2008 |
Medientyp: | unknown |
Schlagwort: |
|
Sonstiges: |
|